389889-80-9

Basic information

• Product Name: 1-BOC-4-HYDROXY-4-(HYDROXYMETHYL)-PIPERIDINE
• Synonyms: 1-BOC-4-HYDROXY-4-(HYDROXYMETHYL)-PIPERIDINE;4-Hydroxy-4-hydroxyMethylpiperidine-1-carboxylic acid tert-butyl ester;1-Boc-4-hydroxy-4-(hydrox...;tert-butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate
• CAS NO: 389889-80-9
• Molecular Formula: C₁₁H₂₁NO₄
• Molecular Weight: 231.29
• EINECS: 200-589-5
• Mol File: 389889-80-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 350.9±27.0 °C(Predicted)
• Appearance: /
• Density: 1.164±0.06 g/cm3(Predicted)
• PKA: 14.06±0.20(Predicted)
• CAS DataBase Reference: 1-BOC-4-HYDROXY-4-(HYDROXYMETHYL)-PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BOC-4-HYDROXY-4-(HYDROXYMETHYL)-PIPERIDINE(389889-80-9)
• EPA Substance Registry System: 1-BOC-4-HYDROXY-4-(HYDROXYMETHYL)-PIPERIDINE(389889-80-9)

Safety Data

• Hazardous Substances Data: 389889-80-9(Hazardous Substances Data)

Usage

General Description

1-BOC-4-HYDROXY-4-(HYDROXYMETHYL)-PIPERIDINE is a chemical compound that consists of a piperidine ring with a hydroxymethyl group and a hydroxyl group, both of which are protected by a BOC (tert-butoxycarbonyl) group. 1-BOC-4-HYDROXY-4-(HYDROXYMETHYL)-PIPERIDINE is commonly used as a reagent in organic synthesis, particularly in the production of pharmaceuticals and other biologically active molecules. The BOC group serves as a protecting group, allowing for selective reaction of the hydroxymethyl and hydroxyl groups while preventing unwanted reactions. Its versatility and stability make it a valuable building block in the field of organic chemistry.

Upstream product

• 159635-49-1 tert-butyl 4-methylidenepiperidine-1-carboxylate 
• 3612-20-2 1-phenylmethyl-4-piperidone 
• 19867-34-6 N-benzyl-1-oxa-6-azaspiro[2,5]-octane 
• 92197-36-9 4-hydroxy-4-(hydroxymethyl)-1-(phenylmethyl)piperidine 
• 89584-31-6 4-(hydroxymethyl)piperidin-4-ol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 297172-16-8 (4-methylpiperidin-4-yl)methanol 
• 189442-87-3 ethyl tert-butyl 4-methylpiperidine-1,4-dicarboxylate 
• 103039-88-9 ethyl 4-methylpiperidine-4-carboxylate 

Downstream Products

• 1257300-52-9 1,1-dimethylethyl 1,3-dioxa-2-thia-8-azaspiro[4.5]decane-8-carboxylate 2,2-dioxide 

Relevant articles and documents

HEPATITIS B ANTIVIRAL AGENTS

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

Ester derivatives

This invention relates to compounds which exhibit selective muscarinic M3 receptor antagonism, have little side effects, are suitable for inhalation therapy and are useful as treating agents of respiratory system diseases, of the general formula (I); 1[in which A signifies a group expressed by a formula (a0) or (b0); 2Ar signifies optionally substituted aryl or heteroaryl; B1 and B2 signify aliphatic hydrocarbon; R1 signifies fluorine-substituted cycloalkyl; R2, R3 and R4 signify lower alkyl, single bond or alkylene bonded to B1, or R2 and R3 are united to signify alkylene; R5 and R7 signify hydrogen, lower alkyl, or a single bond or alkylene bonded to B2; R6 signifies hydrogen, lower alkyl or a group expressed as —N(R8)R9; and X?signifies an anion].